NCT02515188View on ClinicalTrials.gov

The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation.

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 7, 2015

Primary Completion Date

June 23, 2016

Study Completion Date

June 23, 2016

Conditions
Arrhythmia
Interventions
DRUG

Propacetamol

Randomly selected patients of the propacetamol group are given intravenous propacetamol 2g for 15 minutes on the beginning of the procedure.

DRUG

Placebo

Placebo group are given intravenous Normal Saline 2g for 15 minutes on the beginning of the procedure.

Trial Locations (1)

120-752

Department of Anaesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02515188 - The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation. | Biotech Hunter | Biotech Hunter